نتایج جستجو برای: پروبیوتیک abt 10

تعداد نتایج: 1019339  

2013
Edna F. Choo Jason Boggs Chunqiang Zhu Joseph W. Lubach Nathaniel D. Catron Gary Jenkins Andrew J. Souers Richard Voorman

Navitoclax (ABT-263), a Bcl-2 family inhibitor and ABT-199, a Bcl-2 selective inhibitor, are high molecular weight, high logP molecules that show low solubility in aqueous media. While these properties are associated with low oral bioavailability (F), both navitoclax and ABT-199 showed moderate F in preclinical species. The objective of the described study was to determine if lymphatic transpor...

2014
Jide Tian Hoa Dang An Viet Nguyen Zheying Chen Daniel L. Kaufman

Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic responses while ABT-induced regulatory responses arose and spread. γ-Aminobutyric acid (GABA) adm...

Journal: :The European respiratory journal 1998
B Lehnigk K F Rabe G Dent R S Herst P J Carpentier H Magnussen

The novel 5-lipoxygenase (5-LO) inhibitor, ABT-761, was investigated for its effect on exercise-induced bronchoconstriction in asthmatic subjects. The relationship between 5-LO inhibition and effects on the response of the airways to exercise was examined. In a double-blind, randomized, crossover clinical trial, 10 patients with mild to moderate persistent asthma (who exhibited a fall in forced...

Journal: :Journal of the American Society of Nephrology : JASN 2007
Jennifer M Sasser Jennifer C Sullivan Janet L Hobbs Tatsuo Yamamoto David M Pollock Pamela K Carmines Jennifer S Pollock

Endothelin (ET) receptor blockade delays the progression of diabetic nephropathy; however, the mechanism of this protection is unknown. Therefore, the aim of this study was to test the hypothesis that ET(A) receptor blockade attenuates superoxide production and inflammation in the kidney of diabetic rats. Diabetes was induced by streptozotocin (diabetic rats with partial insulin replacement to ...

2014
Richard Tuli Andrew J. Surmak Juvenal Reyes Michael Armour Amy Hacker-Prietz John Wong Theodore L. DeWeese Joseph M. Herman

OBJECTIVES To determine whether poly (ADP-ribose) polymerase-1/2 (PARP-1/2) inhibition enhances radiation-induced cytotoxicity of pancreatic adenocarcinoma in vitro and in vivo, and the mechanism by which this occurs. METHODS Pancreatic carcinoma cells were treated with ABT-888, radiation, or both. In vitro cell viability, apoptosis, and PARP activity were measured. Orthotopic xenografts were...

Journal: :The Journal of pharmacology and experimental therapeutics 2014
Danhui Zhang Matthew McGregor Michael W Decker Maryka Quik

Previous studies in Parkinsonian rats and monkeys have shown that β2-selective nicotinic acetylcholine receptor (nAChR) agonists reduce l-Dopa-induced dyskinesias (LIDs), a serious complication of l-Dopa therapy for Parkinson's disease. Since rodent studies also suggested an involvement of α7 nAChRs in LIDs, we tested the effect of the potent, selective α7 agonist ABT-107 [5-(6-[(3R)-1-azabicyc...

Journal: :Antimicrobial agents and chemotherapy 2003
Melinda M Neuhauser Jennifer L Prause Larry H Danziger Susan L Pendland

The bactericidal activities of ABT-773, a new ketolide, were compared to those of cefuroxime and amoxicillin-clavulanate against 10 strains of Streptococcus pneumoniae containing the ermB gene. MICs and time-kill curves were determined in duplicate per NCCLS guidelines with cation-adjusted Mueller-Hinton broth with 3% lysed horse blood. Viable counts were done at 0, 2, 6, and 24 h. Antibiotic c...

Journal: :Blood 2007
Deepa B Shankar Junling Li Paul Tapang J Owen McCall Lori J Pease Yujia Dai Ru-Qi Wei Daniel H Albert Jennifer J Bouska Donald J Osterling Jun Guo Patrick A Marcotte Eric F Johnson Niru Soni Kresna Hartandi Michael R Michaelides Steven K Davidsen Saul J Priceman Jenny C Chang Katrin Rhodes Neil Shah Theodore B Moore Kathleen M Sakamoto Keith B Glaser

In 15% to 30% of patients with acute myeloid leukemia (AML), aberrant proliferation is a consequence of a juxtamembrane mutation in the FLT3 gene (FMS-like tyrosine kinase 3-internal tandem duplication [FLT3-ITD]), causing constitutive kinase activity. ABT-869 (a multitargeted receptor tyrosine kinase inhibitor) inhibited the phosphorylation of FLT3, STAT5, and ERK, as well as Pim-1 expression ...

2014
Danhui Zhang Matthew McGregor Michael W. Decker Maryka Quik

Previous studies in Parkinsonian rats and monkeys have shown that b2-selective nicotinic acetylcholine receptor (nAChR) agonists reduce L-Dopa–induced dyskinesias (LIDs), a serious complication of L-Dopa therapy for Parkinson’s disease. Since rodent studies also suggested an involvement of a7 nAChRs in LIDs, we tested the effect of the potent, selective a7 agonist ABT-107 [5-(6-[(3R)-1-azabicyc...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Scot Ebbinghaus Maha Hussain Nizar Tannir Michael Gordon Apurva A Desai Raymond A Knight Rod A Humerickhouse Jiang Qian Gary B Gordon Robert Figlin

PURPOSE Angiogenesis is a characteristic of renal cell carcinoma. ABT-510 is an angiogenesis inhibitor that mimics the antiangiogenic properties of thrombospondin-1. This study was designed to assess the safety and efficacy of ABT-510 in patients with advanced renal cell carcinoma. EXPERIMENTAL DESIGN Patients with previously untreated metastatic or unresectable renal cell carcinoma were rand...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید